HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Alfredo Trento Sharo Raissi Jack M. Matloff Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Trento, A. Articles by Matloff, J. M. Search for Related Content PubMed PubMed Citation Articles by Trento, A. Articles by Matloff, J. M.

J Thorac Cardiovasc Surg 1996;112:1496-1503
© 1996 Mosby, Inc.

CARDIAC AND PULMONARY REPLACEMENT

CLINICAL EXPERIENCE WITH ONE HUNDRED CONSECUTIVE PATIENTS UNDERGOING ORTHOTOPIC HEART TRANSPLANTATION WITH BICAVAL AND PULMONARY VENOUS ANASTOMOSES

Received for publication May 6, 1996 revisions requested June 17, 1996; revisions received July 22, 1996 accepted for publication August 30, 1996. Address for reprints: Alfredo Trento, MD, Cedars-Sinai Medical Center, No. 6215, 8700 Beverly Blvd., Los Angeles, CA 90048.

Abstract

Objective: Our objective was to assess survival, need for pacemaker insertion, and rejection frequency with a new surgical technique of orthotopic heart transplantation using bicaval and pulmonary venous anastomoses.
Methods: We retrospectively reviewed 100 consecutive patients who had orthotopic heart transplantation with this technique between July 1991 and September 1995.
Results: The mean age was 57.0 ± 11.1 years, with 51 patients being 60 years or older. The mean donor/recipient weight ratio was 0.92, and in 28 patients the ratio was less than 0.8. The early (30-day) survival was 100% and the 1- and 2-year survivals were 98% ± 2% and 96% ± 2%, respectively. Survival was not affected by age or by the duration of the OKT3 therapy (p > 0.2 for each of these parameters). The seven late deaths were due to infection (n = 2), graft atherosclerosis (n = 3), acute rejection (n = 1), and nonspecific graft failure (n = 1). No permanent pacemaker was required in the first 6 months after the operation, and all the patients were discharged in normal sinus rhythm. Freedom from treated rejection was significantly greater in patients with 7 days of OKT3 therapy than in patients with 14 days of therapy (p < 0.0001).
Conclusions: Orthotopic heart transplantation with bicaval and pulmonary venous anastomoses offers an improved alternative to the standard biatrial technique, with a 30-day mortality of 0% in 100 consecutive patients, excellent intermediate-term survival, and elimination of the need for pacemaker insertion. More normal anatomic configuration and synchronous function of the atria may have contributed to these results. (J THORAC CARDIOVASC SURG 1996;112:1496-503)

This article has been cited by other articles:

				H. Antretter, F. Hintringer, H. Hangler, E. Gassner, D. Hoefer, J. Kilo, J. Margreiter, G. Laufer, and G. Poelzl Electromechanical synchronization of the heterotopic and native heart by dual atrial stimulation following heart transplantation. Europace, April 1, 2006; 8(4): 279 - 282. [Abstract] [Full Text] [PDF]

				G. B. Luciani, G. Faggian, G. Montalbano, G. Casali, A. Forni, B. Chiominto, and A. Mazzucco BLOOD VERSUS CRYSTALLOID CARDIOPLEGIA FOR MYOCARDIAL PROTECTION OF DONOR HEARTS DURING TRANSPLANTATION: A PROSPECTIVE, RANDOMIZED CLINICAL TRIAL J. Thorac. Cardiovasc. Surg., November 1, 1999; 118(5): 787 - 795. [Abstract] [Full Text] [PDF]

				D. Y. Sze, R. C. Robbins, C. P. Semba, M. K. Razavi, and M. D. Dake Superior vena cava syndrome after heart transplantation: percutaneous treatment of a complication of bicaval anastomoses J. Thorac. Cardiovasc. Surg., August 1, 1998; 116(2): 253 - 257. [Abstract] [Full Text] [PDF]

				J. M. Matloff and A. Chaux Cardiothoracic Surgery JAMA, June 18, 1997; 277(23): 1843 - 1845. [PDF]